Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PAOG Targets $18 Billion Anxiety And Depression Treatment Market
https://finance.yahoo.com/news/paog-targets-18-billion-anxiety-140700160.html
Steff07,
Try http://www.usmj.com instead.
HC
PAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory Approval
https://finance.yahoo.com/news/paog-signs-clinical-research-organization-132000366.html
A few interviews with Saul Kaye.
Saul Kaye interviewed on i24news July 2020:
1st and 2nd Quarter reports for 2020 are out:
https://www.otcmarkets.com/stock/PAOG/disclosure
2019 Annual Report is out:
https://backend.otcmarkets.com/otcapi/company/financial-report/255994/content
Tomorrow's MoneyTV interview with Jim today..............http://moneytv.net
PAOG Acquires Revenue Generating Cannabis Cultivation Operation Developing Proprietary Cultivar For Medical Research
July 28 2020 - 06:58PM
Sandusky, OH -- July 28, 2020 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced the acquisition of a cannabis cultivation operation from Puration, Inc. (USOTC: PURA). The acquisition is part of PAOG’s overall medical cannabis revitalization strategy that includes the planned acquisition of a patented cannabis extraction operation from Kali-Extracts (USOTC: KALY) anticipated to close later this week on Thursday, July 30, 2020. The PURA cannabis cultivation operation acquired from PURA is working to develop a proprietary cultivar to support the ongoing research conducted by the KALY patented cannabis extraction operation PAOG is acquiring.
The cannabis cultivation operation headquartered in Texas has an estimated $300,000 in annual revenue. Texas lawmakers have recently implemented hemp friendly farming regulations and in so doing, universities within the State of Texas have initiated hemp farming research programs. The cannabis cultivation spinoff has initiated a number of joint research applications with Texas universities.
PAOG next week plans to publish a comprehensive overview on the background of the cannabis cultivation operation and the patented cannabis extraction operation to also include PAOG’s plans going forward with the two operations.
The cannabis cultivation operation was valued at $1,000,000 in the deal between PAOG and PURA. PAOG is issuing common stock in exchange for the cannabis cultivation operation. PURA plans to issue an independent press release on plans to distribute the PAOG purchase stock to PURA shareholders in a dividend distribution.
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
samsamsamiam,
High End Times..........sounds like The Stoner's Guide To the Apocalypse.
That's not intended to be a hyphen. A capsule shape is formed between the 2 N's and that is just the center of the capsule.
Effective immediately, resignations have been tendered to PAO GROUP INC. as follows:
Karl-Heinz Riedel IV hereby resigns as Chief Executive Officer (CEO), President, and board member.
Effective immediately, resignations have been tendered to PAO GROUP INC. as follows:
— PAO Group $PAOG (@PAOgroup) September 10, 2019
Karl-Heinz Riedel IV hereby resigns as Chief Executive Officer (CEO), President, and board member. pic.twitter.com/ti0hBCFSqb
Steve,
Here's the link to the winners from Clio:
https://hightimes.com/news/the-winners-of-the-2019-michigan-cannabis-cup/
There is a Best Vape Pen and Best CBD Vape Pen Category. Both Cannophen vapes, the Pink Mimosa vape and the C-Cup Premium THC Distillate 510 Cart would be entered in one or both categories.
No clue what category the Cannophen capsules would be entered in based on the 16 categories shown. Guess it's possible there were more than 16 categories for the Detroit Cup.
Can you imagine being a judge?.....tough job but somebody's gotta do it.
HC
PS Appreciate your past posts and humor.
Murdoc,
The HTCC in Clio was held the weekend of June 8-9......results were announced on Tuesday the 11th. Could be we see the winners today if they follow suit.
More good pics of the High End booth at the cup:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150595505
Big thanks to this boots-on-the-ground investor for sharing.
Erbmanus,
Great pics....thanks for sharing them plus your thoughts on what you saw and heard.
So you've got permission to grow in MO? That ought to be an interesting adventure. I see MO's Amendment 2 allows you to grow at one time up to 18 plants......with 6 in the flowering stage.....6 in the vegetative stage......and 6 seedlings.
https://www.news-leader.com/story/news/local/ozarks/2019/07/03/missouri-medical-marijuana-amendment-2-patients-grow-weed/3745937002/
Thanks for the pics and all the best to part-time farming.
HC
PS Could you post your pics on the PAOG board?
Doc,
Here are pics of the winners.....16 categories.... of the High Times Cannabis Cup in Clio earlier this year. Of note.....the Church Cannabis Co. Key Fob vape and the CBD Vape Pens by Lightsky Farms.....getting first and second.
https://hightimes.com/news/the-winners-of-the-2019-michigan-cannabis-cup/
Wonder what category our capsule products were entered in?
For those of us that don't use FB, porkypigg, myself and others, is there any way you can post the FB video to youtube or some other site?
Thanks,
HC
Michigan is experiencing a medical marijuana drought
https://www.metrotimes.com/detroit/michigan-is-experiencing-a-medical-marijuana-drought/Content?oid=22380915
Marijuana users have often been plagued by the August drought: those dog days of late summer that fall between harvests in Mexico or somewhere when there was simply no weed available, when you went down your list of dealers and struck out on every one with a "call me back in a week or two" response.
The droughts have been less regular since the advent of home grows, although the vagaries of the growing cycles can sometimes still throw your timing off. That said, right now Michigan is in the midst of an August drought. A couple of weeks ago a text message came out from Corktown provisioning center BotaniQ saying that they were out of flowers. Since then the location's co-owner Anqunette Jamison Sarfoh has been in the media saying that they have only a few selections of flowers at the location. Few others seem to be able to have adequate supplies either.
Jerry Millen, an owner of the Greenhouse in Walled Lake, reports that location has about 21 varieties, but not much of any of them. "We probably have about two weeks' worth of flower left," he says. "Then [we'll] be totally out. There is no flower to be had anywhere."
That may depend on where you are, and what and how much you're looking for. A perusal of the Facebook Michigan Medical Marijuana Growers page shows some evidence of the search for flowers. One frustrated member posted "Straight up! F*ckin (sic) DRY SEASON. END THE DROUGHT!"
Another member responded, "I live in the Amsterdam of Michigan (Ann Arbor) and it has been super dry for at least a month now. Can't find lbs. anywhere."
There are several posts that belie that sentiment, but those tend to be from the southwest part of the state. There are other posts that question the quality of what is available. One narrative around the drought is that caregiver flowers of questionable quality are used to make extracts, while only best buds are sold in their natural state.
Of course, product has always been scarce in the Michigan system. For years, growing your own or using caregivers was the only way to legally access medical cannabis. When a medical system came in, some administrators were unfriendly and downright antagonistic to getting it going.
Has there ever been enough medical marijuana? A quick perusal of media this past year shows headlines pointing out a medical marijuana shortage last November, and in January, May, and June of this year. So maybe there is always a medical marijuana shortage. However, the level of complaining has intensified in recent weeks.
Maybe that intensification is due to the Marijuana Regulatory Agency tweaking how caregivers' products enter the medical marijuana market. Previously, caregivers' products could be sold in provisioning centers if customers signed a document acknowledging that the cannabis is untested. Now that policy has changed, resulting in less product available.
There seems to be plenty of edibles and oils on the shelves of provisioning centers. Michigan is not yet a "mature" marijuana market, and old-school flowers remain the product of choice for the majority of users. People are used to using it that way, and like it. They understand how to use it and what to expect when they use it. New ways of doing that have not yet replaced the tried and true methods.
Although most of this drought talk is anecdotal, it's backed by information distributed by Confident Cannabis, a company with software that helps marijuana businesses to test, sell, and buy wholesale cannabis. According to press materials, 50 percent of the legal cannabis produced in the country — across 25 states — passes through the Confident Cannabis lab testing platform.
The company is moving into Michigan and has collected some interesting information about the cannabis market. The initial findings are that there's not enough product, the caregiver and retail relationship is changing, and there is an abundance of extracts. We kind of knew that already, but it's nice that other folks are backing up what we're seeing.
One thing we do need in our system is more growers. Most people who want to enter the marijuana business system want to sell the product rather than grow it. That makes sense. At a basic level, growing looks more complicated than selling. Literally speaking, growers get about three harvests per year per space. You can't make the plants grow that much faster, and if you stagger the plantings it just means less product at a time — whereas the prospect of retail sales presents a possibility for unfettered sales. But where are you going to get it?
Not from Oregon, where a reported surplus of marijuana exists, and prices are at least half of what they are here.
That all points to the fact that Michigan's medical marijuana system still hasn't gotten its legs under it yet. The so-called black market is still vibrant, and people seem to have more trust in the folks they've been buying from the past decade or more.
The medical marijuana system should be delivering for patients with an unbroken supply. They should never have to worry about where they can find what they need. The idea of a marijuana drought should be a thing of the past, but it is emphatically a thing of the present.
This August drought looks like it could well extend into September, as headlines of the past year indicate. Personally, I'm not affected by this yet because I made a bulk acquisition a couple of months back that is seeing me through all this. Not everybody can do that. From the perspective of the average patient, things don't seem to be getting better.
New High End tweet:
Introducing C-CUP™ 510 Cartridges featuring cutting-edge vapor technology, including unique ceramic dual-heating element "cups" to deliver maximum flavor & vapor.
https://twitter.com/gethighend
Murdoc,
I would consider it a significant win......if just one product out of the four they've entered......places in the Top Three of any category. This is a tough competition, with many entries by past winners and those that have placed at previous cups.
HC
PAOG is now current........yield sign lifted.
https://www.otcmarkets.com/stock/PAOG/disclosure
Attorney letter has been filed....
https://www.otcmarkets.com/stock/PAOG/disclosure
Photos of High End Products C-Cup Cartridges and packaging......which will be one of their entries at the High Times Cannabis Cup.....appears this is 'Pink Mimosa'.......an all THC distillate vape.
https://twitter.com/PAOgroup
Latest tweet:
Preparing our entries for the #HIGHTIMES Cannabis Cup!
Can't wait to share more details!
https://twitter.com/PAOgroup
New tweet:
Packaging for #Cannophen THC/CBD Premium Blend Capsules and #BroadSpectrum #CBD Capsules is finalized and ready for print - we are planning to launch both variations at the #HIGHTIMES #CannabisCup Detroit on August 17th-18th.
https://twitter.com/PAOgroup
Everyone who has been here a while or has done their DD knows that the city of Romulus chose to opt out of the marijuana business......therefore PAOG is looking for another location. Mr. Riedel.....in his 2nd Money TV interview......mentioned he received a letter from the Romulus city attorney stating this fact. I suppose we'll continue to see more incorrect info posted by these mindless drones.
That's not true.....Romulus chose to opt out..........they won't allow any MMJ businesses in their community.
If you're going to pump this, at least get some facts straight. There is no such thing as a class 3 grower in Michigan.
That's not exactly true.
PAOG has the exclusive licensing rights to manufacture RBII's complete line of cannabis products (including Cannophen) in the state of Michigan.
https://www.globenewswire.com/news-release/2019/02/11/1716692/0/en/PAOG-Officially-Appoints-Karl-Riedel-as-New-CEO-and-President.html
Doc,
In the interview, Mr. Riedel stated:
"We’ve been working diligently on a strategic partnership with a Class C grower and provisioning center in Detroit to distribute Cannophen throughout Michigan."
One Class C license allows for a grow op of up to 1,500 plants at a time...and multiple C licenses can be stacked and grown at same location. That's a good start for a dependable source of cannabis product to manufacture Cannophen and High End Products.......plus the provisioning center to boot.
Another interesting statement to me was at the CannaCon trade show they attended seminars on packaging and licensing. Hopefully there they received some helpful info.
Things are looking up.
HC
PS. Mr. Riedel's interview...bottom left corner of screen is a cap that says USALAB. Wonder if he got that has a handout at CannaCon....or if they purchased some of their distillation and other lab products. https://www.usalab.com/
Doc,
Link previously sent to you was updated this morning......nothing in it we're looking for.
Could you post Cream's 'White Room'? Can't seem to remember the words.....thought it goes like this but not sure:
In the white room….like black curtains….stands Pat Blasko
Is this the place….where Tom will race….to make the grass grow?
In the white room….he can milk the….THC cow
Grow the good plant….make the distillate….like he knows how
We’re waiting for you….to make this all come true
LOL
HC
LEARN ABOUT CANNABIS
Indica vs. Sativa: Know Your Cannabis Subspecies
With more than 1,000 strains of cannabis having been bred during the past several decades, it is critical that patients are aware of the different types of efficacy available to them in terms of cannabis medicine. Some varieties of cannabis are most appropriate for particular diseases and ailments, but not others. Choosing the right strain is critical to ensuring that patients receive the best therapy possible.
Cannabis is a species of flowering herb that is split into three subspecies: Indica, sativa, and ruderalis. Ruderalis plants are small and yield relatively little medicine; what they do provide lacks potency and is generally not appealing to patients. Because of this, ruderalis strains are typically avoided by breeders and cultivators; the focus of the medical cannabis community is on indica and sativa strains.
Indica and sativa plants differ not only in their physiological effects, but also in their appearance. Indica plants are short and stocky, featuring leaves that are broad and “chunky.” Sativa plants tend to be taller and skinnier and may even be lanky in appearance, with leaves that are thin and pointed.
Medical Efficacy
The most important difference between these two subspecies of cannabis, however, is in their medical effects and how they influence energy levels and productivity. Indicas tend to decrease energy and are better for consumption in the evening or at night, after the conclusion of the day’s work and activities. Potent indica strains may give some patients what is called “couchlock,” a condition in which they become so relaxed that they care barely get up from the sofa.
Sativas, on the other hand, are uplifting and cerebral, enhancing creativity and productivity. Indicas provide what has been called a “body high,” while sativas deliver more of a “mind high.” Unfortunately, sativa plants require longer to grow and yield less medicine (flowers) than indica varieties. This is why indica strains have traditionally dominated those available on the black market, where there is no concern for patient need and the sole focus is profit.
The fact that patients are given no choice of subspecies or strain when purchasing from the black market is a major reason it should be avoided. Patients should never trust or consume cannabis medicine without knowing its exact strain and that it was properly grown, dried, cured, and laboratory tested for purity and potential contamination.
Modern cultivators of medical cannabis purposefully breed and grow a wide spectrum of strains within both the indica and sativa categories for the purpose of making available the right medicine for a particular patient’s unique combination of disease, preference, and lifestyle. Often, patients must maintain jobs or family responsibilities that demand a particular energy level and can’t tolerate the sedative properties of many indicas. Other times, patients must seek the most potent non-opiate painkiller possible. Given the choice of chronic pain or the mellowing effects of a strong indica of a particular strain known for its medical benefits, most patients will choose the latter.
Because cultivators and dispensaries are sensitive to the subjective efficacy of particular strains for different patients, they grow and make available as many strains as possible for targeted ailments. Major conditions of focus include HIV/AIDS, cancer, fibromyalgia, glaucoma, Parkinson’s, all types of arthritis, and epilepsy, among many others.
In terms of particular ailments, sativa strains tend to be better for psychological disorders like depression, PTSD, and anxiety. Indicas are often the best for pain and inflammation and, thus, are beneficial for patients with arthritis, fibromyalgia, and cancer. However, because so many diseases are accompanied by side effects like depression and insomnia, a patient must consider treating both their core disease and also its daily symptoms. In the end, each patient will favor multiple strains that will likely fall within the categories of sativa, hybrid, and indica.
When it comes to aroma, indica strains tend to emit musty, earthy, and skunky odors, while sativas smell sweet, fruity, or spicy. This difference in aroma is the result of terpenes, the molecules within the plant that are cousins to cannabinoids like THC and CBD. While these chemicals provide sometimes stunningly pungent odors, their greatest benefit to patients is actually their medicinal efficacy.
Understanding Hybrids
Hybrids are simply new and unique strains that are bred from parents of different types. A hybrid theoretically possesses many or most of the beneficial medical properties of both its parents. Breeders can “cross” any two strains they desire in an effort to create a new strain that delivers the best possible medical efficacy, sometimes for particular diseases like lupus, multiple sclerosis, Crohn’s disease, and epilepsy.
It should be noted that any two strains can be mixed to create a hybrid. While indica/sativa mixes are common and often noted for their “alert mellowness” and productivity, medical cannabis breeders can also mix indicas with other indicas or use two sativas as parents.
With so many hybrid strains available to patients, many are a compromise that possess the ability to kill pain and fight inflammation while not putting a patient to sleep in the middle of the day. Patients who must medicate in the morning or mid-day, typically for nausea and pain, often prefer a sativa-dominant hybrid, but will switch to an indica-dom strain in the evenings and for maximum pain relief.
Hybrid strains that display more indica than sativa traits are labeled “indica-dom,” while those that lean toward sativa are similarly dubbed “sativa-dom.” Often, strains are labeled with a sativa/indica ratio, like a 60/40 sativa/indica. Other times a strain will indicate only a percentage, such as “70 percent indica” or “80 percent sativa”.
Landrace Strains & Heirlooms
Landrace strains are those that evolved naturally within their native environments. Because they weren’t bred and aren’t hybrids, landrace strains offer a very pure example of sativa or indica, with no interference from humans. In fact, landrace strains are typically 100 percent indica or sativa, the result of tens of thousands of years of inbreeding in a particular weather climate and geography.
Heirlooms are landrace strains that have been grown outside of their native environment, such as plants or seeds professionally grown in Illinois that originated on the other side of the world. While sought for their pure indica or sativa characteristics, such strains lose some of their unique characteristics when grown outside the climate in which they evolved.
Examples of landrace strains include Durban Poison, a sativa from South Africa; Afghan Indica, from Afghanistan; Malawi Gold, a sativa from Southeastern Africa; and Panama Red, a sativa from the country that bears its name.
Landrace sativas appear in Asia, Anatolia, and Northern Africa. These climates provide the long summers and intense sun in which such strains have evolved and adapted to thrive. Indicas are located in Afghanistan, India, and Pakistan. Such strains will not reach their potential if grown within indoor or outdoor conditions that don’t match those of their native environment.
Eastern Europe, the Himalayan region of India, and Siberia are home to ruderalis landrace strains and are among the least desired of these naturally evolved plants. Often, as in the Himalayas, such plants are used to create traditional hand-rolled hash, with impoverished villagers in such regions subsisting on black market sales of the concentrate that eventually appears in smoking cafes throughout Europe.
What Determines Sativa or Indica?
Readers have already learned that the sometimes pungent aromas produced by many strains of cannabis are the result of terpenes, the special molecules in the herb that are similar in many respects to cannabinoids like THC and CBD.
While many might guess that a particular strain of cannabis is categorized as indica, sativa, or hybrid based on the presence or absence of a particular cannabinoid, or a cannabinoid in a particular volume, it is actually a terpene that determines this important status of a strain.
Myrcene, the most common terpene in cannabis, is known to help patients sleep, battling conditions like anxiety and insomnia. If present in a specific strain in a volume greater than 0.5 percent, the strain is considered an indica. If the amount of myrcene is under one half of one percent, then the strain is deemed a sativa.
This dynamic is a good example of the entourage effect, a theory that cannabinoids and terpenes work together in harmony to deliver medicinal efficacy to patients. Many terpenes buffer or enhance the effects of major cannabinoids like THC.
New Strains Constantly Being Created
New strains of cannabis, many of which are hybrids of existing strains that display exceptional analgesic (pain killing) or anti-inflammatory qualities, are being created on a regular basis. While some strains are better at dealing with the nausea associated with chemotherapy (used to treat patients with cancer and Crohn’s, among other diseases), most types of cannabis are very good at this.
With such dramatic differences between indicas and sativas in terms of medicinal efficacy and the experience of the patient, those legally using medical cannabis should work with their physician and dispensary to experiment with various strains that are already known to deliver exceptional benefits to other sufferers, especially those with the same condition.
Patients must strive to find the strains that best deal with their particular disease or ailment and its symptoms, including the side effects of any pharmaceutical drugs or therapies. This is typically not an overnight project and may require months or even years of diligent effort. In fact, patients are encouraged to continually experiment with new strains in search of greater potency or a superior cannabinoid profile that delivers improved relief.
Because this efficacy is so subjective, the advice of other patients can be given only so much weight. The true test of a particular strain of indica or sativa occurs only when used by an individual patient when they most need it, such as during bouts of pain, nausea, or insomnia.
https://www.crescolabs.com/indica-vs-sativa
That is nonsense and absurd.
RSB Management is Riedel, Sawyer, Blasko
Doc,
Been keeping an eye on this for several weeks now. Week of June 10 - June 14 just came out this morning......nothing PAOG related yet though:
https://www.michigan.gov/lara/0,4601,7-154-89334_79571_93032-497636--,00.html
doc,
On twitter also:
Cannophen launch at the HIGHTIMES Cannabis Cup Michigan was a success!
PAOG debuted Cannophen capsules and Cannophen vape cartridges with a 1:1 blend of premium THC distillate and full-spectrum CBD distillate.
https://twitter.com/PAOgroup
This past weekend at the Cannabis Cup was a blast! As always, we were excited to meet both veterans of the cannabis space and those who are fresh-faced and new. Everyone who entered the competition brought their best products and their A-Game. Without further ado, here are the winners of the 2019 Michigan Cannabis Cup:
https://www.countable.us/articles/29268-winners-2019-michigan-cannabis-cup
Louie,
No sir I'm not...but am looking forward to seeing pictures of the event.
BTW I did live and work in the Midland and Bay City area for a year, 1978-79. Enjoyed my time there. Met Bob Seger in a hall at the Midland Holiday Inn and he couldn't have been nicer.
Thanks Rowdyboy,
Fender Benders Edibles, the first announced line of products from High End. Interesting logo (by 48 Hours logo).....with the red-eyed stoned-look drooling sports car.
https://twitter.com/gethighend
Looking forward to seeing what their display/exhibit area looks like at Clio and learning about the edible products High End has in store.
Louie,
That's certainly a possibility.
New tweet this morning:
#PAOG is proud to announce the launch of #Cannophen capsules ?? at the #HIGHTIMES Cannabis Cup Michigan! ??
Stop by and see us June 8th-9th!
https://twitter.com/PAOgroup
Doc,
A "launch" to me could be something as simple as they announce that Cannophen with THC/CBD is now available at one or two...or a few...Michigan MMJ dispensaries. I'd be happy with that for now...product on dispensary shelves....that would be a big deal. And of course High End Products and Cannophen being displayed at this weekends cannabis cups High Times’ exhibitor village.
This article below is from today...I'd prefer music along the lines of Pink Floyd, Skynyrd or the Stones.......but rapper fans should be pleased with the lineup for this weekend.
https://www.globenewswire.com/news-release/2019/06/07/1865884/0/en/High-Times-Announces-Busta-Rhymes-Lil-Skies-for-Upcoming-Michigan-Cannabis-Cup.html